Surveillance and Correlation of Antibiotic Prescription and Resistance of Gram-Negative Bacteria in Singaporean Hospitals

被引:101
作者
Hsu, Li-Yang [1 ]
Tan, Thean-Yen [2 ]
Tam, Vincent H. [1 ,3 ]
Kwa, Andrea [4 ]
Fisher, Dale Andrew [1 ]
Koh, Tse-Hsien [5 ]
机构
[1] Natl Univ Hlth Syst, Dept Med, Singapore 119074, Singapore
[2] Changi Gen Hosp, Dept Lab Med, Singapore 529889, Singapore
[3] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[4] Singapore Gen Hosp, Dept Pharm, Singapore 169608, Singapore
[5] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore
关键词
ANTIMICROBIAL RESISTANCE;
D O I
10.1128/AAC.01076-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A surveillance study was performed in four Singapore public hospitals from 2006 to 2008 to determine the correlation between antibiotic prescription and Gram-negative bacterial antimicrobial resistance. Targeted organisms included ceftriaxone- and ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae, as well as imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. Antibiotic prescription data were collated in the WHO anatomical therapeutic chemical (ATC)/defined daily dose (DDD) format, while antibiotic resistance was expressed as incidence density adjusted for total inpatient-days every quarter. Individual trends were determined by linear regression, while possible associations between antibiotic prescription and resistance were evaluated via cross-correlation analysis. Results over 3 years indicated significantly rising incidence densities of ceftriaxone- and ciprofloxacin-resistant E. coli and imipenem-resistant Acinetobacter spp. (blood isolates only). Antimicrobial-resistant Klebsiella pneumoniae rates declined. The prescription rates of piperacillin-tazobactam, ertapenem, meropenem, ciprofloxacin, and levofloxacin increased significantly, while imipenem and moxifloxacin prescription decreased. Cross-correlation analysis demonstrated possible associations between prescription of fluoroquinolones and ciprofloxacin-resistant E. coli (R-2 = 0.46), fluoroquinolones and ceftriaxone-resistant E. coli (R-2 = 0.47), and carbapenems and imipenem-resistant Acinetobacter spp. (R-2 = 0.48), all at zero time lag. Changes in meropenem prescription were associated with a similar trend in imipenem-resistant Acinetobacter blood isolates after a 3-month time lag. No correlation was found between cephalosporin use and resistance. In conclusion, our data demonstrated correlation between prescription of and Gram-negative bacterial resistance to several, but not all, key antimicrobial agents in Singapore hospitals. In areas where Gram-negative bacterial resistance is endemic and prescription of broad-spectrum antimicrobial agents is high, factors other than antimicrobial usage may be equally important in maintaining high resistance rates.
引用
收藏
页码:1173 / 1178
页数:6
相关论文
共 20 条
[1]   High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption [J].
Bartoloni, A ;
Bartalesi, F ;
Mantella, A ;
Dell'Amico, E ;
Roselli, M ;
Strohmeyer, M ;
Barahona, HG ;
Barrón, VP ;
Paradisi, F ;
Rossolini, GM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07) :1291-1294
[2]   Association between Antimicrobial Consumption and Resistance in Escherichia coli [J].
Bergman, Miika ;
Nyberg, Solja T. ;
Huovinen, Pentti ;
Paakkari, Pirkko ;
Hakanen, Antti J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) :912-917
[3]   Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].
Boucher, Helen W. ;
Talbot, George H. ;
Bradley, John S. ;
Edwards, John E., Jr. ;
Gilbert, David ;
Rice, Louis B. ;
Scheld, Michael ;
Spellberg, Brad ;
Bartlett, John .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12
[4]  
*CLIN LAB STAND I, 2005, M100S14 CLIN LAB STA, V24
[5]  
Clinical and Laboratory Standards Institute, 2006, M39A2 CLIN LAB STAND, V25
[6]   Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis [J].
Colgan, Richard ;
Johnson, James R. ;
Kuskowski, Michael ;
Gupta, Kalpana .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) :846-851
[7]   Antimicrobial Drug Use and Resistance in Europe [J].
de Sande-Bruinsma, Nienke Van ;
Grundmann, Hajo ;
Verloo, Didier ;
Tiemersma, Edine ;
Monen, Jos ;
Goossens, Herman ;
Ferech, Matus .
EMERGING INFECTIOUS DISEASES, 2008, 14 (11) :1722-1730
[8]   Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. [J].
Goossens, H ;
Ferech, M ;
Stichele, RV ;
Elseviers, M .
LANCET, 2005, 365 (9459) :579-587
[9]   Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007 [J].
Hawser, Stephen P. ;
Bouchillon, Samuel K. ;
Hoban, Daryl J. ;
Badal, Robert E. ;
Hsueh, Po-Ren ;
Paterson, David L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) :3280-3284
[10]   Antimicrobial drug resistance in Singapore hospitals [J].
Hsu, Li-Yang ;
Tan, Thean-Yen ;
Jureen, Roland ;
Koh, Tse-Hsien ;
Krishnan, Prabha ;
Lin, Raymond Tzer-Pin ;
Tee, Nancy Wen-Sin ;
Tambyah, Paul Ananth .
EMERGING INFECTIOUS DISEASES, 2007, 13 (12) :1944-1947